Portuguese Hospitals' breast cancer drug patterns revealed
NCT ID NCT07223476
Summary
This study looked back at how doctors in Portugal actually prescribed and adjusted specific breast cancer medications in real hospital settings. Researchers analyzed drug use data from 16 public hospitals between 2018 and 2023 to understand treatment patterns, how long patients stayed on medications, and how often doses were reduced. The goal was to learn from everyday medical practice, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.